
Proteonano™
Ultraplex Proteomics Platform
High-multiplex technology allows for the discovery of protein biomarkers

Multiplex + UltraDepth
Detect 1,000-5,000 plasma proteins and biomarkers in a single run, spanning 9 orders of magnitude in abundance.
High Throughput
Greatly simplify sample prep, allowing the workstation to process 100 samples per day per unit.
Unknown Protein
Provides broad analysis of the entire proteome, including post-translational modifications, allelic variations, and alternative splicing.
Seamless Integration
Seamlessly fits into existing LS-MS workflows, compatible with various LS-MS, and requires no extra large equipment.

Technical Assessment
We take pride in our numbers
4000
PGs identified
pg/mL
Sensitivity
9 logs
Dynamic range
15%
Median CV%
70%
Low abundance proteins

Unprecedented Sensitivity.
Reliable Precision.
Humans have around 25,000 protein-coding genes. The human proteome, derived from the genome, includes over one million proteins, with more than 20,000 unique proteins found in the blood proteome.
Over 95% of FDA-approved drugs target proteins, yet most components of the proteome remain unexplored. In the next decade, proteomics is set to take center stage, ushering in a new era of protein-focused drug development and diagnostics.
Latest News
A New Chapter Begins: Nanomics Biotech Teams Up with Vita Analytics
PRESS RELEASE: We’re excited to formally announce our exclusive distributionship with Vita Analytica. As part of this agreement, we will supply Vita with the full suite of our Proteonano™ Ultraplex Proteomics Platform to support the standardization of its omics services platforms and enable deeper, reproducible fluids & FFPE proteome profiling.
